Literature DB >> 19554266

Transcriptional profiles during the differentiation and maturation of monocyte-derived dendritic cells, analyzed using focused microarrays.

Weixue Zhong1, Min Fei, Yibei Zhu, Xueguang Zhang.   

Abstract

Dendritic cells (DC) are professional antigen-presenting cells capable of initiating primary immune responses. They have been intensively studied and are used in both basic immunology research and clinical immunotherapy. However, the genetic pathways leading to DC differentiation and maturation remain poorly understood. Using focused microarrays with oligonucletotide probes for 120 genes encoding co-stimulatory molecules, chemokines, chemokine receptors, cytokines, cytokine receptors, TLRs, and several other related molecules, we analyzed the kinetics of gene expression for the overall differentiation process of monocytes into mature DC. In parallel, we compared the transcriptional profiles in DC maturation in the presence of LPS, TNF-alpha or trimeric CD40L. We found similar transcriptional profiles for early immature DC and immature DC, respectively generated by culturing monocytes with GM-CSF and IL-4 for three or six days. We identified sets of common and stimuli-specific genes, the expression of which changed following stimulation with LPS, TNF-alpha or CD40L. A dynamic analysis of the entire DC differentiation and maturation process showed that some important inflammatory and constitutive chemokines are transcribed in both immature and mature DC. The correlative expression kinetics of the gene pairs IL1R1/IL1R2, IL15/IL15RA, DC-SIGN/ICAM-2 and DC-SIGN/ICAM-3 imply that they all play crucial roles in mediating DC functions. Thus, our analysis with focused microarrays shed light on the transcriptional kinetics of DC differentiation and maturation, and this method may also prove useful for identifying novel marker genes involved in DC functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554266      PMCID: PMC6275667          DOI: 10.2478/s11658-009-0023-3

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  61 in total

Review 1.  Dendritic cells: development, function and potential use for cancer immunotherapy.

Authors:  D Avigan
Journal:  Blood Rev       Date:  1999-03       Impact factor: 8.250

2.  Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation.

Authors:  Ludmila Jirmanova; Dragana Jankovic; Albert J Fornace; Jonathan D Ashwell
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  Leptin-specific patterns of gene expression in white adipose tissue.

Authors:  A Soukas; P Cohen; N D Socci; J M Friedman
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

4.  Selectivity release of the type II decoy IL-1 receptor.

Authors:  S Orlando; N Polentarutti; A Mantovani
Journal:  Cytokine       Date:  2000-07       Impact factor: 3.861

5.  A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.

Authors:  M Takekawa; H Saito
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis.

Authors:  Francesca Zazzeroni; Salvatore Papa; Alicia Algeciras-Schimnich; Kellean Alvarez; Tiziana Melis; Concetta Bubici; Nathan Majewski; Nissim Hay; Enrico De Smaele; Marcus E Peter; Guido Franzoso
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

8.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

Authors:  M Cella; D Scheidegger; K Palmer-Lehmann; P Lane; A Lanzavecchia; G Alber
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

10.  Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis.

Authors:  Urs Eriksson; Michael O Kurrer; Ivo Sonderegger; Giandomenica Iezzi; Anna Tafuri; Lukas Hunziker; Shinobu Suzuki; Kurt Bachmaier; Roland M Bingisser; Josef M Penninger; Manfred Kopf
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  4 in total

1.  Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen.

Authors:  R D Fannin; K Gerrish; S O Sieber; P R Bushel; P B Watkins; R S Paules
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

2.  Gene expression profiles identify inflammatory signatures in dendritic cells.

Authors:  Anna Torri; Ottavio Beretta; Anna Ranghetti; Francesca Granucci; Paola Ricciardi-Castagnoli; Maria Foti
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

3.  RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation.

Authors:  Ana Estecha; Noemí Aguilera-Montilla; Paloma Sánchez-Mateos; Amaya Puig-Kröger
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

4.  Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions.

Authors:  Masakatsu D Yanagimachi; Akira Niwa; Takayuki Tanaka; Fumiko Honda-Ozaki; Seiko Nishimoto; Yuuki Murata; Takahiro Yasumi; Jun Ito; Shota Tomida; Koichi Oshima; Isao Asaka; Hiroaki Goto; Toshio Heike; Tatsutoshi Nakahata; Megumu K Saito
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.